- |||||||||| Journal: MONKEYPOX AND PREGNANCY: FORECASTING THE RISKS. (Pubmed Central) - Aug 21, 2022
Obstetric concerns relating to antiviral therapy with tecovirimat and vaccinia immune globulin, including the risks of QTc prolongation, erroneous blood glucose monitoring and venous thromboembolism, are highlighted. Finally, we discuss the possibility of monkeypox vaccine hesitancy during pregnancy, offer strategies to mitigate these risks and propose research priorities to address knowledge gaps about the impact of monkeypox infection on maternal, fetal, and neonatal health.
- |||||||||| ACAM2000 (smallpox (vaccinia) live vaccine) / Emergent Biosolutions
177 - Clinical Controversies (207 AB) - Jul 23, 2022 - Abstract #IDWeek2022IDWEEK_342; Finally, we discuss the possibility of monkeypox vaccine hesitancy during pregnancy, offer strategies to mitigate these risks and propose research priorities to address knowledge gaps about the impact of monkeypox infection on maternal, fetal, and neonatal health. CME Credits : Maximum of 1.25 hours of AMA PRA Category 1 Creditâ„¢ MOC Credits : Maximum of 1.25 hours of MOC Credit CNE Credits : Maximum of 1.25 hours of ANCC Credit No CPE Credit Offered Learning Objectives: At the conclusion of this session, participants will be able to: discuss the ethical issues surrounding COVID-19 vaccine requirements for SOT candidates describe the risk/benefit considerations of the use of ACAM2000 in potentially immune compromised recipients in an ongoing outbreak
- |||||||||| Journal: Prevention and Treatment of Monkeypox. (Pubmed Central) - Jul 16, 2022
Antivirals can be considered in severe disease, immunocompromised patients, pediatrics, pregnant and breastfeeding women, complicated lesions, and when lesions appear near the mouth, eyes, and genitals. The purpose of this short review is to describe each of these countermeasures.
|